Atlas Trials

Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT00469898 · COMPLETED

Trial details

NCT number
NCT00469898
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2003-12-01
Primary completion
2008-07-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.